261 related articles for article (PubMed ID: 19308726)
1. Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression.
Fu J; Weise AM; Falany JL; Falany CN; Thibodeau BJ; Miller FR; Kocarek TA; Runge-Morris M
Breast Cancer Res Treat; 2010 Feb; 120(1):35-45. PubMed ID: 19308726
[TBL] [Abstract][Full Text] [Related]
2. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
3. Expression level of enzymes related to in situ estrogen synthesis and clinicopathological parameters in breast cancer patients.
Suzuki M; Ishida H; Shiotsu Y; Nakata T; Akinaga S; Takashima S; Utsumi T; Saeki T; Harada N
J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):195-201. PubMed ID: 19159687
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinoma.
Takagi K; Moriya T; Kurosumi M; Oka K; Miki Y; Ebata A; Toshima T; Tsunekawa S; Takei H; Hirakawa H; Ishida T; Hayashi S; Kurebayashi J; Sasano H; Suzuki T
Horm Cancer; 2013 Feb; 4(1):1-11. PubMed ID: 23096432
[TBL] [Abstract][Full Text] [Related]
5. Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.
Ferlin A; Ganz F; Pengo M; Selice R; Frigo AC; Foresta C
Endocr Relat Cancer; 2010 Mar; 17(1):17-25. PubMed ID: 19776291
[TBL] [Abstract][Full Text] [Related]
6. Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma.
Singh S; Chakravarti D; Edney JA; Hollins RR; Johnson PJ; West WW; Higginbotham SM; Cavalieri EL; Rogan EG
Oncol Rep; 2005 Oct; 14(4):1091-6. PubMed ID: 16142378
[TBL] [Abstract][Full Text] [Related]
7. New development in intracrinology of breast carcinoma.
Sasano H; Suzuki T; Nakata T; Moriya T
Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
[TBL] [Abstract][Full Text] [Related]
8. The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism.
Hevir-Kene N; Rižner TL
Chem Biol Interact; 2015 Jun; 234():309-19. PubMed ID: 25437045
[TBL] [Abstract][Full Text] [Related]
9. Expression of estrogen-metabolizing enzymes and estrogen receptors in cholelithiasis gallbladder.
Svoboda M; Sellner F; Ekmekcioglu C; Klimpfinger M; Jaeger W; Thalhammer T
Biomed Pharmacother; 2008 Dec; 62(10):690-6. PubMed ID: 18440760
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
Wihlén B; Ahmed S; Inzunza J; Matthews J
Mol Cancer Res; 2009 Jun; 7(6):977-86. PubMed ID: 19470599
[TBL] [Abstract][Full Text] [Related]
11. Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer.
Smuc T; Rupreht R; Sinkovec J; Adamski J; Rizner TL
Mol Cell Endocrinol; 2006 Mar; 248(1-2):114-7. PubMed ID: 16337331
[TBL] [Abstract][Full Text] [Related]
12. Disturbed expression of phase I and phase II estrogen-metabolizing enzymes in endometrial cancer: lower levels of CYP1B1 and increased expression of S-COMT.
Hevir N; Sinkovec J; Rižner TL
Mol Cell Endocrinol; 2011 Jan; 331(1):158-67. PubMed ID: 20887769
[TBL] [Abstract][Full Text] [Related]
13. Mutual regulations and breast cancer cell control by steroidogenic enzymes: Dual sex-hormone receptor modulation upon 17β-HSD7 inhibition.
Sang X; Han H; Li T; Lin SX
J Steroid Biochem Mol Biol; 2019 Oct; 193():105411. PubMed ID: 31207361
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 induces CYP1B1 expression via ligand-independent activation of the ERalpha pathway in human breast cancer cells.
Han EH; Kim HG; Hwang YP; Song GY; Jeong HG
Toxicol Sci; 2010 Apr; 114(2):204-16. PubMed ID: 20093341
[TBL] [Abstract][Full Text] [Related]
15. Estradiol 17β and its metabolites stimulate cell proliferation and antagonize ascorbic acid-suppressed cell proliferation in human ovarian cancer cells.
Li HH; Zhao YJ; Li Y; Dai CF; Jobe SO; Yang XS; Li XF; Patankar MS; Magness RR; Zheng J
Reprod Sci; 2014 Jan; 21(1):102-11. PubMed ID: 23757313
[TBL] [Abstract][Full Text] [Related]
16. Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells.
Sundar SN; Marconett CN; Doan VB; Willoughby JA; Firestone GL
Carcinogenesis; 2008 Dec; 29(12):2252-8. PubMed ID: 18784357
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
[TBL] [Abstract][Full Text] [Related]
18. The role of estrogen-metabolizing enzymes and estrogen receptors in human epidermis.
Inoue T; Miki Y; Abe K; Hatori M; Hosaka M; Kariya Y; Kakuo S; Fujimura T; Hachiya A; Aiba S; Sasano H
Mol Cell Endocrinol; 2011 Sep; 344(1-2):35-40. PubMed ID: 21740958
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen.
Wu X; Subramaniam M; Grygo SB; Sun Z; Negron V; Lingle WL; Goetz MP; Ingle JN; Spelsberg TC; Hawse JR
Breast Cancer Res; 2011 Mar; 13(2):R27. PubMed ID: 21392396
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in genes involved in the estrogen pathway and mammographic density.
Dumas I; Diorio C
BMC Cancer; 2010 Nov; 10():636. PubMed ID: 21092186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
